NBIX · Neurocrine Biosciences Inc · Documents
$145.53
-0.47 (-0.32%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$14.84B
Shares
101.65M
Volume · Oct 28
877.23K
Avg daily vol (3M)
1.32M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2021-11-01 | 2021-09-30 | |
| 8-K | — | 2021-08-03 | — | |
| 10-Q | — | 2021-08-03 | 2021-06-30 | |
| 8-K | — | 2021-05-21 | 2021-05-19 | |
| 8-K | — | 2021-05-05 | — | |
| 10-Q | — | 2021-05-05 | 2021-03-31 | |
| 8-K | — | 2021-04-16 | 2021-04-15 | |
| DEF 14A | — | 2021-04-09 | 2021-05-19 | |
| DEFA14A | — | 2021-04-09 | — | |
| 10-K | — | 2021-02-05 | 2020-12-31 | |
| 8-K | — | 2021-02-04 | — | |
| 8-K | — | 2021-02-02 | — | |
| 8-K | — | 2021-01-08 | — | |
| 8-K | — | 2020-11-24 | 2020-11-23 | |
| 8-K | — | 2020-11-19 | 2020-11-18 | |
| 8-K | — | 2020-11-09 | — | |
| 10-Q | — | 2020-11-09 | 2020-09-30 | |
| 8-K | — | 2020-09-10 | 2020-09-09 | |
| 8-K | — | 2020-08-28 | — | |
| 8-K | — | 2020-08-03 | — | |
| 10-Q | — | 2020-08-03 | 2020-06-30 | |
| 8-K | — | 2020-07-28 | — | |
| 8-K | — | 2020-07-13 | — | |
| 8-K | — | 2020-06-16 | 2020-06-12 | |
| 8-K | — | 2020-05-21 | 2020-05-19 | |
| 8-K | — | 2020-05-06 | — | |
| 10-Q | — | 2020-05-06 | 2020-03-31 | |
| DEF 14A | — | 2020-04-09 | 2020-05-19 | |
| 8-K | — | 2020-04-09 | 2020-04-06 | |
| DEFA14A | — | 2020-04-09 | — | |
| 10-K | — | 2020-02-07 | 2019-12-31 | |
| 8-K | — | 2020-02-05 | 2020-02-04 | |
| 8-K | — | 2020-02-04 | 2020-02-01 | |
| 8-K | — | 2020-01-13 | 2020-01-12 |
Showing 101–134 of 134 filings
Key facts
CIK
914475
CUSIP
64125C109
13F (30d)
195 filings
184 filers
Visit website
Investor relations